Join the 'Singulair' group to help and get support from people like you.
FDA Medwatch Alert: FDA announces voluntary recall of Montelukast tablets by Camber Pharmaceuticals due to incorrect drug in bottles
Posted 4 Sep 2018 by Drugs.com
The U.S. Food and Drug Administration is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets – lot number MON17384, expiration 12/31/2019 – by Camber Pharmaceuticals, Inc., Piscataway, N.J. Sealed bottles labeled as montelukast sodium tablets, 10 milligram, 30-count bottle from Camber were found to instead contain 90 tablets of Los...
Posted 21 Sep 2017 by Drugs.com
THURSDAY, Sept. 21, 2017 – The asthma medication Singulair (montelukast) appears linked to neuropsychiatric side effects, such as depression, aggression, nightmares and headaches, according to a new review by Dutch researchers. But experts aren't yet ready to pull the plug on this class of medication. "In our study, we give prescribing physicians the advice to be alert for signs and symptoms for...
FDA Medwatch Alert: Singulair (montelukast)
Posted 27 Mar 2008 by Drugs.com
[Posted 03/27/2008] FDA informed healthcare professionals and patients of the Agency's investigation of the possible association between the use of Singulair and behavior/mood changes, suicidality (suicidal thinking and behavior) and suicide. Singulair is a leukotriene receptor antagonist used to treat asthma and the symptoms of allergic rhinitis, and to prevent exercise-induced asthma. Patients...